Novavax (NVAX): Too Soon To Evaluate US Vaccination Rates - Bloomberg
Go back to Novavax (NVAX): Too Soon To Evaluate US Vaccination Rates - Bloomberg| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.13 | 52 Week High | $9.23 | |||
| Open | $9.13 | 52 Week Low | $1.16 | |||
| Day High | $9.13 | P/E | N/A | |||
| Day Low | $9.13 | EPS | $-0.30 | |||
| Volume | 8,387 | |||||

